Form EFFECT Anebulo Pharmaceuticals,

March 3, 2025 6:06 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 28, 2025 5:00 P.M.
Form: S-3
CIK: 0001815974
Company Name: Anebulo Pharmaceuticals, Inc.
File Number: 333-285098


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings